MFN2 and liver dysplastic nodule: Mfn2 can inhibit mitochondrial morphological and functional abnormalities by reducing oxidative stress, endoplasmic reticulum stress and autophagy, and ultimately delay the development of DN, so it may be a potential target for DN therapy.